Treatment with Ivermectin Increases the Population of Bifidobacterium in the Gut

Hazan et al., ACG 2023, Oct 2023

Source

PDF

All
Studies

Meta
Analysis

Ivermectin for COVID-19

4th treatment shown to reduce risk in August 2020, now with p < 0.00000000001 from 105 studies, recognized in 24 countries.

Lower risk for mortality, ventilation, ICU, hospitalization, recovery, cases, and viral clearance.

No treatment is 100% effective. Protocols combine treatments.

5,500+ studies for 121 treatments. c19ivm.org

Analysis of the effect of ivermectin on the gut microbiome, showing a significant increase in Bifidobacterium.

Bifidobacterium plays a key role in the immune system, for example enhancing antibody production, facilitating the induction of regulatory T cells, modulating the immune response of macrophages, dendritic cells, and T cells, maintaining gut barrier integrity, and inhibiting harmful microbes.

Increased Bifidobacterium is associated with lower COVID-19 severity1.

Important missing comments or errors? Let us know.

Study covers probiotics and ivermectin.

1. Taufer et al., The Role of Bifidobacterium in COVID-19: A Systematic Review, Life, doi:10.3390/life13091847.mdpi.com, doi.org.

Hazan et al., 22 Oct 2023, preprint, 4 authors.

This Paper Ivermectin All

Please send us corrections, updates, or comments. c19early involves the extraction of 100,000+ datapoints from thousands of papers. Community updates help ensure high accuracy. Treatments and other interventions are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. IMA and WCH provide treatment protocols.

Submit

Post

@CovidAnalysis

FAQ

Public domain CC0 1.0